Drugs / Pegylated rhEPO
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01800305 | Sep 2012 → Oct 2014 | — | Xiamen Amoytop Biotech Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pegylated rhEPO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01800305 ↗ |
| Route | Subcutaneous | “single-dose subcutaneous administration” NCT01800305 ↗ |